PF-Atlas › Clinical Trials › NCT04594369
A Study to Assess the Efficacy, Safety, and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis
Brensocatib 10 mg · Phase 3
Registry ID
NCT04594369
Phase
Phase 3
Status
Completed
Drug / intervention
Brensocatib 10 mg
Sponsor
Insmed Incorporated
Start
2020-12-01
About this trial
Brensocatib 10 mg is evaluated in NCT04594369, a Phase 3 idiopathic pulmonary fibrosis study sponsored by Insmed Incorporated. Current status: Completed.
Explore related
Related trials
Medical disclaimer. This page summarizes public trial data for NCT04594369 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.